Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1

SAR 221.50 puts Dr. Sulaiman Al Habib Medical Services stock 5.43 percent above its low

Published on 10/14/2026 at 12:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half net income reached SAR 1.17 billion in 2026, down 1.37 percent. Dr. Sulaiman Al Habib Medical Services stock costs SAR 221.50 on October 14, 2026, down 2.38 percent on Tadawul.

Healthcare valuation and earnings

First-half net income totaled SAR 1.17 billion in 2026, down 1.37 percent from the prior year.
Dr. Sulaiman Al Habib Medical Services carried a SAR 77.5 billion market capitalization on October 14, 2026.
Dr. Sulaiman Al Habib Medical Services stock stood at SAR 221.50 on October 14, 2026 at 12:59 p.m. AST, down 2.38 percent versus the prior close of October 13, 2026.
The stock traded at a P/E ratio of 32.05 on October 14, 2026.

Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1, Illustration mit AI erstellt.

SAR 221.50 puts Dr. Sulaiman Al Habib Medical Services stock 5.43 percent above its 52-week low. The stock was trading on Tadawul at 12:59 p.m. AST on October 14, 2026, down 2.38 percent from the prior close of SAR 226.90 on October 13, 2026, with the listing and ISIN confirmed by Global Banking and Finance.

First-half profit slips

According to Borsa Talk, net income for the first half of 2026 was SAR 1.17 billion, down 1.37 percent from SAR 1.18 billion in the first half of 2025. The result gives the market a current earnings anchor while the share price remains 21.22 percent below its 52-week high of SAR 281.20.

Stock stays above its yearly low

The current SAR 221.50 price is SAR 11.40 above the 52-week low of SAR 210.10, a 5.43 percent premium calculated from the Tadawul quote. The 52-week range extends to SAR 281.20, leaving the stock 21.22 percent below its high. Trading volume was 45,644 shares at 12:59 p.m. AST, compared with an average volume of 137,784 shares.

Valuation and healthcare peers

The company had a SAR 77.5 billion market capitalization and a P/E ratio of 32.05 on October 14, 2026. Its dividend yield was 0.02 percent, while the two selected Saudi healthcare peers traded at lower P/E ratios.

Comparison with peers

Dr. Sulaiman Al Habib Medical Services: minus 2.38 percent, P/E 32.05, market capitalization SAR 77.5 billion
Mouwasat Medical Services Company (Tadawul, SAR): minus 2.50 percent, P/E 14.19, market capitalization SAR 12.1 billion
Dallah Healthcare Company (Tadawul, SAR): minus 3.09 percent, P/E 17.17, market capitalization SAR 7.6 billion

Saudi healthcare valuation in view

The session places Dr. Sulaiman Al Habib Medical Services between a large valuation base and weaker same-day performance from both named peers. The earnings comparison is also relevant: first-half net income declined 1.37 percent, while the P/E ratio remained above the peer readings of 14.19 and 17.17.

The latest quote was SAR 221.50 on Tadawul on October 14, 2026 at 12:59 p.m. AST, down 2.38 percent versus the prior close of SAR 226.90 on October 13, 2026. The further course of trading is shown by the continuously updated real-time quote of Dr. Sulaiman Al Habib Medical Services stock.